Corbus Pharmaceuticals Holdings (CRBP) Cash & Equivalents Growth (1y) (2014 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Cash & Equivalents Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 988.88% |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -68.22% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 4.77% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 3.35% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 269.98% |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 17.50% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - | 123.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 123.36% |
| Sep 30, 2025 | 31.21% |
| Jun 30, 2025 | -7.46% |
| Mar 31, 2025 | 281.29% |
| Dec 31, 2024 | 25.33% |
| Sep 30, 2024 | 873.11% |
| Jun 30, 2024 | 189.77% |
| Mar 31, 2024 | -32.32% |
| Dec 31, 2023 | 154.79% |
| Sep 30, 2023 | -83.96% |
| Jun 30, 2023 | -69.61% |
| Mar 31, 2023 | -43.41% |
| Dec 31, 2022 | -79.16% |
| Sep 30, 2022 | -66.48% |
| Jun 30, 2022 | -32.40% |
| Mar 31, 2022 | 282.44% |
| Dec 31, 2021 | -78.63% |
| Sep 30, 2021 | -54.66% |
| Jun 30, 2021 | -49.23% |
| Mar 31, 2021 | 114.02% |